Your browser doesn't support javascript.
loading
Estrogen receptor ß upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
Li, Mei; Chai, Hui-Fang; Peng, Fei; Meng, Yu-Ting; Zhang, Li-Zhi; Zhang, Lin; Zou, Hong; Liang, Qi-Lan; Li, Man-Man; Mao, Kai-Ge; Sun, Dong-Xu; Tong, Meng-Ying; Deng, Zi-Qian; Hou, Zhi-Jie; Zhao, Yi; Li, Jia; Wang, Xiao-Chao; Lv, Sha-Sha; Zhang, Qing-Qing; Yu, Xiao; Lam, Eric W-F; Liu, Quentin; Cui, Xiao-Nan; Xu, Jie.
Afiliação
  • Li M; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Chai HF; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
  • Peng F; Dongfang Hospital, Key Laboratory of Health Cultivation of the Ministry of Education, Beijing University of Chinese Medicine, Beijing, China.
  • Meng YT; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang LZ; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang L; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
  • Zou H; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liang QL; Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Li MM; Dalian Municipal Women And Children's Medical Center, Dalian, China.
  • Mao KG; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Sun DX; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Tong MY; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Deng ZQ; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Hou ZJ; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhao Y; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Li J; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wang XC; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Lv SS; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zhang QQ; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Yu X; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Lam EW; The First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Liu Q; Departmemt of Pathology, Dalian Medical University, Dalian, China.
  • Cui XN; Departmemt of Pathology, Dalian Medical University, Dalian, China.
  • Xu J; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Cell Death Dis ; 9(11): 1120, 2018 11 02.
Article em En | MEDLINE | ID: mdl-30389909
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Neoplasias da Glândula Tireoide / Regulação Neoplásica da Expressão Gênica / Receptor beta de Estrogênio / RNA Longo não Codificante / Câncer Papilífero da Tireoide Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Neoplasias da Glândula Tireoide / Regulação Neoplásica da Expressão Gênica / Receptor beta de Estrogênio / RNA Longo não Codificante / Câncer Papilífero da Tireoide Idioma: En Ano de publicação: 2018 Tipo de documento: Article